• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Reports

Reports

Microbiome Drug Database Update: March 2021

March 4, 2021 Microbiome Times

You must be logged in to view this content. Please login here or if you do not have an account register here.

Reports

Microbiome-based diagnostics and biomarkers: Changing the paradigm in microbiology and medicine

February 3, 2021 Luis Gosálbez

Abstract Knowledge about the human microbiome is requiring scientists to re-define the relationship between microbes and disease, going beyond Koch’s Postulates and incorporating concepts such as holobiont – understanding human physiology as the sum of […]

Reports

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

October 26, 2020 Luis Gosálbez

Over the past several years as microbiome drug development programs continued to advance worldwide, the entire industry looked to the most clinically advanced companies to see whether their Phase 2 and 3 clinical trials would […]

Reports

The Microbiome Biotech Landscape: An Analysis of the Pharmaceutical Pipeline

October 8, 2020 Luis Gosálbez

Introduction The microbiome is one of the hottest areas in biotechnology, as countless studies have linked its composition and activity with human disease1,2, especially in illnesses of poorly understood mechanisms, with high medical unmet needs. […]

Reports

Microbiome after coronavirus: Investing in the power of microbes

October 8, 2020 Luis Gosálbez

The COVID-19 crisis is causing immense suffering and an appalling death toll. It has also dramatically impacted our personal and professional lives, and individuals, businesses and investors can’t wait to get back to normalcy. However, […]

  • Microbiome Drug Database Update: March 2021
    March 4, 2021
  • Microbiome-based diagnostics and biomarkers: Changing the paradigm in microbiology and medicine
    February 3, 2021
  • The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry
    October 26, 2020
  • The Microbiome Biotech Landscape: An Analysis of the Pharmaceutical Pipeline
    October 8, 2020
  • Microbiome after coronavirus: Investing in the power of microbes
    October 8, 2020
sign up

Sign up to the Microbiome Times newsletter